US EditionPublished • loading... • Updated
South Africa: Ozempic, Wegovy and the R33bn Bill That Is SA's Obesity Time Bomb
Obesity costs South Africa R33-billion in 2020 and limits access to surgery and costly lifelong drugs amid stigma and funding challenges, experts say.
Summary by allAfrica
2 Articles
2 Articles
South Africa: Ozempic, Wegovy and the R33bn Bill That Is SA's Obesity Time Bomb
Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective treatments. The gap between the scale of the problem and the funding response is widening, with long-term consequences for patients, insurers and the public purse.
·South Africa
Read Full Article
Ozempic, Wegovy and the R33bn bill that is SA's obesity time bomb
Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective treatments. The gap between the scale of the problem and the funding response is widening, with long-term consequences for patients, insurers and the public purse.
·South Africa
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
